We now explored in more detail, in how far the auxiliary assessment of ERCC1-transcripts influences overall CTC-detection rate and whether this molecular marker may improve the phenotypic range of CTC-detection by the AdnaTest Ovarian Cancer platform. The gene discussed is ERCC1; the disease is ovarian carcinoma.